Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults.
dc.contributor.author | ayitenkore, K | |
dc.contributor.author | Omosa-Manyonyi, G | |
dc.contributor.author | Bwayo, J | |
dc.contributor.author | Karita, E | |
dc.contributor.author | Jaoko, WG | |
dc.contributor.author | Schmidt, C | |
dc.contributor.author | Gilmour, J | |
dc.contributor.author | Boaz, M | |
dc.contributor.author | Than, S | |
dc.contributor.author | Graham, B | |
dc.date.accessioned | 2013-12-02T12:30:25Z | |
dc.date.available | 2013-12-02T12:30:25Z | |
dc.date.issued | 2007 | |
dc.identifier.citation | ayitenkore K, Omosa-Manyonyi G, Bwayo J, Karita E, Jaoko WG, Schmidt C, Gilmour J, Boaz M, Than S & Graham B (2007) Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults. CROI, Los Angeles, USA | en |
dc.identifier.uri | http://hdl.handle.net/11295/61436 | |
dc.language.iso | en | en |
dc.publisher | University of Nairobi | en |
dc.title | Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults. | en |
dc.type | Presentation | en |
local.publisher | School of Medicine | en |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |